ONC Q1 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q1 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$43M

Operating Income

-$52M

Net Income

-$51M

EPS (Diluted)

$-1.27

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$43M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$377M

Total Liabilities

$68M

Stockholders' Equity

$308M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$677,000	-100.0%
Gross Profit	-$43M	-$17M	-148.7%
Operating Income	-$52M	-$20M	-153.5%
Net Income	-$51M	-$22M	-130.1%